iSpecimen Inc. 8-K

What Happened
iSpecimen Inc. (ISPC) filed a Form 8-K on February 6, 2026 (Regulation FD disclosure) announcing two press releases. The first announced successful completion of Milestone 2 in the company’s digital transformation program with SalesStack Solutions and the activation of iSpecimen’s live production marketplace. The second highlighted recent operational achievements in the company’s site network, including rapid procurement of influenza specimens to support customer research.

Key Details

• Filing: Form 8-K, filed February 6, 2026, under Item 7.01 (Regulation FD Disclosure).
• Milestone: Completion of Milestone 2 in the digital transformation program powered by SalesStack Solutions; live production marketplace was activated.
• Operations: Press release notes operational wins demonstrating the strength and responsiveness of the company’s site network, including rapid influenza specimen procurement.
• Exhibits: The two press releases are furnished as Exhibits 99.1 and 99.2 to the 8-K.

Why It Matters
These announcements signal progress on iSpecimen’s product and operational initiatives: activating a live production marketplace is a concrete step in commercializing its platform, and faster specimen procurement demonstrates operational capability to support customer research. For investors, the updates are material as they relate to how the company delivers service and scales its marketplace—factors that can affect future revenue generation and customer retention. The filing itself is informational (Regulation FD disclosure) and does not include financial results or executive changes.